Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CYRX vs SLGB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CYRX Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

CYRX Overall Winner 6-Pillar Tally: CYRX 4 – 2 SLGB Matrix Metrics: CYRX 7 – 3 SLGB

As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CYRX carries a Unified Composite Score of 39.7/100 (SELL) at $19.79 (93.5x Forward P/E, -14.4% operating margin), whereas SLGB carries 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin).

  • Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 39.7/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY).
  • Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 59.1); meanwhile SLGB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CYRX vs SLGB
CYRX NASDAQ Head-to-Head Winner
CryoPort, Inc. Common Stock
Pharmaceutical Preparations
$19.79
-0.53% 1D
Market Cap $1.0B
TTM Revenue $192M
Forward P/E 93.5x
Beta / 30D Vol 1.59β · 85% Vol
Unified Composite Score
39.7 / 100 SELL
Tech 8.0 Fund 36.0 Flow 64.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.2% over 20 days), RSI 59
RSI-14: 59.1 · SMA20: $18.41 · SMA50: $17.51
SLGB US Equity
SLGB
Institutional Equity
$0.18
+0.39% 1D
Market Cap $8.1M
TTM Revenue $629M
Forward P/E N/M
Beta / 30D Vol -0.06β · 207% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 55.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -30.9%), weak momentum, RSI 38
RSI-14: 38.4 · SMA20: $0.22 · SMA50: $0.27

6-Pillar Scorecard Institutional Category Breakdown (CYRX 4 – 2 SLGB)

Columns: Metric · CYRX · SLGB
1. Valuation Multiples CYRX
Forward P/E 93.5x N/M
Trailing P/E 93.5x N/M
PEG Ratio N/M N/M
EV / Revenue 5.0x N/M
2. Growth & Scale CYRX
Revenue Growth (YoY) +13.5% -22.1%
Earnings Growth (YoY) +0.0% +356.9%
TTM Revenue (USD) $192M $629M
Market Cap $1.0B $8.1M
3. Profitability & Quality SLGB
Gross Margin 46.9% 4.7%
Operating Margin -14.4% -2.3%
Net Profit Margin -21.5% -2.9%
Return on Equity (ROE) -7.4% -14.7%
4. Balance Sheet & Cash Flow SLGB
Cash Generation (TTM) -$20M -$12M EBITDA
Cash Flow Margin -10.3% -2.0% EBITDA Mgn
Net Cash / Leverage $48M Net Cash $0.47 Book/Sh · -14.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CYRX
Options Structure Phase BREAKOUT UNCLASSIFIED
Current IV / %ile 44.3% (6th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase ACCUMULATION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CYRX
OpEx & R&D Intensity 61.3% of Rev ($118M) 7.0% of Rev ($44M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Integrated Freight & Logistics Operator Integrated Freight & Logistics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CYRX (7) vs SLGB (3)
Institutional Metric CYRX SLGB Criterion Row Edge
Market Capitalization
Scale
$1.0B $8.1M Larger Scale CYRX
Trailing P/E Ratio
Valuation
93.5x N/M Lower Multiple CYRX
Forward P/E Ratio
Valuation
93.5x N/M Lower Multiple CYRX
Revenue Growth (YoY)
Growth
+13.5% -22.1% Higher Growth CYRX
Operating Margin (TTM)
Profitability
-14.4% -2.3% Higher Margin SLGB
Net Profit Margin
Profitability
-21.5% -2.9% Higher Margin SLGB
Return on Equity (ROE)
Capital Efficiency
-7.4% -14.7% Higher ROE CYRX
52-Week Range Position
Momentum
86% ($8–$22) 1% ($0–$4) Stronger Trend CYRX
Beta / 30D Volatility
Risk Regime
1.59β · 85% Vol -0.06β · 207% Vol Lower Realized Risk CYRX
Unified Institutional Score
Composite Signal
39.7 / 100 (SELL) 47.2 / 100 (HOLD) Higher Composite SLGB
Trailing 12M Revenue (USD)
Operating Scale
$192M $629M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
46.9% 4.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 5.0x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$20M ($48M Net Cash) -$12M EBITDA ($0.47 Book/Sh · -14.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CYRX +34.34 pp
CYRX: +17.49% · SLGB: -16.85%
3M Horizon CYRX +97.26 pp
CYRX: +31.11% · SLGB: -66.15%
6M Horizon CYRX +113.63 pp
CYRX: +48.65% · SLGB: -64.98%
1Y Horizon CYRX +216.76 pp
CYRX: +125.86% · SLGB: -90.9%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYRX vs SLGB. Trailing 12-month operating profitability (CYRX -14.4% vs SLGB -2.3%) and valuation multiples (CYRX 93.5x vs SLGB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CYRX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$192M
Gross Margin46.9%
Op. Margin-14.4%
ROE / Fwd P/E-7.4% · 93.5x
SLGB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$629M
Gross Margin4.7%
Op. Margin-2.3%
ROE / Fwd P/E-14.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CYRX BREAKOUT
115d in phase · OBV ACCUMULATION
Current IV 44.3%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CYRX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SLGB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SLGB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CYRX Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $1.0B market capitalization and -14.4% operating margin.
OpEx & R&D Reinvestment 61.3% of Rev ($118M)
90D Engineering Disclosures 0 Published
SLGB Moat Profile Cyclical / Execution-Driven Positioning
Integrated Freight & Logistics Operator
Competes within the Integrated Freight & Logistics value chain with $8.1M market capitalization and -2.3% operating margin.
OpEx & R&D Reinvestment 7.0% of Rev ($44M)
90D Engineering Disclosures 0 Published

Investor FAQ CYRX vs SLGB Key Questions & Quantitative Answers

As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CYRX carries a Unified Composite Score of 39.7/100 (SELL) at $19.79 (93.5x Forward P/E, -14.4% operating margin), whereas SLGB carries 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin). Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 39.7/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY). Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 59.1); meanwhile SLGB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CYRX leads the Growth & Scale pillar: CYRX posts +13.5% YoY revenue growth and +0.0% YoY earnings growth on $192M TTM revenue (46.9% gross margin, -14.4% operating margin), compared with SLGB at -22.1% YoY revenue growth and +356.9% YoY earnings growth on $629M TTM revenue (4.7% gross margin, -2.3% operating margin). On trailing 12-month operating scale, CYRX generates $192M in USD-normalized revenue versus $629M for SLGB. In operating R&D and SG&A reinvestment, CYRX deploys 61.3% of Rev ($118M) (0 90-day corporate R&D disclosures) versus 7.0% of Rev ($44M) (0 disclosures) for SLGB.

CYRX screens cheaper on headline valuation multiples. CYRX trades at 93.5x Forward P/E, 93.5x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (-10.3% FCF margin), whereas SLGB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-2.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CYRX (-7.4% ROE) versus SLGB (-14.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CYRX carries 44.3% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.59β · 85% Vol realized risk). By comparison, SLGB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.06β · 207% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.